Results 271 to 280 of about 4,676,099 (307)

A Cascade Nanozyme with Amplified Sonodynamic Therapeutic Effects through Comodulation of Hypoxia and Immunosuppression against Cancer.

ACS Nano, 2021
The tumor microenvironment (TME) featured by immunosuppression and hypoxia is pivotal to cancer deterioration and metastasis. Thus, regulating the TME to improve cancer cell ablation efficiency has received extensive interest in oncotherapy.
Na Tao, Huihuang Li, Liu Deng, Senfeng Zhao, Ouyang Jiang, Mei Wen, Wansong Chen, Ke Zeng, Chuanwan Wei, Younian Liu   +9 more
semanticscholar   +1 more source

Immunosuppressive Therapy for Asthma

Allergy and Asthma Proceedings, 1995
Over the last four or five years, there have been some serious attempts to look for alternatives to corticosteroids in the management of severe bronchial asthma. Rheumatologists and dermatologists long ago recognized the importance of replacing corticosteroids with other agents.
openaire   +2 more sources

Opioid Therapy and Immunosuppression

American Journal of Therapeutics, 2004
The idea that opioids modulate the immune system is not new. By the late 19th century, Cantacuzene, used morphine to suppress cellular immunity and lower the resistance of guinea pigs to bacterial infection. While exogenous opioids mediate immunosuppression, endogenous opiates exert opposite actions.
Oscar A. de Leon-Casasola, Ramsun Benyamin, Ricardo Vallejo   +2 more
openaire   +3 more sources

Dermatologic Therapy With Immunosuppressive Agents

Postgraduate Medicine, 1975
The use of powerful immunosuppressive agents such as methotrexate, cyclophosphamide, and azathioprine in the treatment of serious skin diseases is a relatively recent development whose efficacy is borne out in many studies. Using an immunosuppressant often makes possible an appreciable reduction in dosage of steroid necessary to control disease and, in
Robert I. Rudolph, James J. Leyden
openaire   +3 more sources

Immunosuppression Therapy in Kidney Transplantation.

Urologic clinics of North America, 2022
Oshorenua Aiyegbusi, E. McGregor, S. McManus, Kate I Stevens   +3 more
semanticscholar   +1 more source

Immunosuppressive drug therapy

Current Opinion in Rheumatology, 1996
Intravenous cyclophosphamide therapy for autoimmune disease continues to be the subject of many clinical trials, which in general have strongly supported its use in lupus nephritis but have failed to demonstrate efficacy in severe vasculitis or severe Wegener's granulomatosis.
openaire   +2 more sources

Immunosuppressive therapy of autoimmune diseases

Immunology Today, 1993
Ciclosporin and cyclophosphamide show a remarkable efficacy in most autoimmune diseases. However, their effect is dependent on continuous drug administration with risks of drug toxicity and over immunosuppression. Results recently obtained in animal models, discussed here by Jean François Bach particularly with anti-CD3 and anti-CD4 monoclonal ...
openaire   +4 more sources

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.

Journal of Clinical Oncology, 2018
PURPOSE To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment.
R. Taplitz, E. Kennedy, E. Bow, J. Crews, C. Gleason, D. Hawley, A. Langston, L. Nastoupil, M. Rajotte, K. Rolston, L. Strasfeld, C. Flowers   +11 more
semanticscholar   +1 more source

Immunosuppressive Therapy in Renal Transplantation

Surgical Clinics of North America, 1971
Standard immunosuppressive therapy currently in use is discussed with emphasis upon the mode and site of action. Immunosuppressive therapy is accompanied by many complications, and often it is necessary to modify the dosage for reasons other than rejection. The manner in which this is done at the Cleveland Clinic is described.
Kathryn L. Popowniak, Satoru Nakamoto
openaire   +3 more sources

IMMUNOSUPPRESSIVE THERAPY IN WEGENER'S GRANULOMATOSIS

Acta Medica Scandinavica, 1970
Abstract. The case history of a 26‐year‐old woman with Wegener's granulomatosis is presented. There were clinical signs of cutaneous, pulmonary, mastoidal and renal involvements. During an oliguric period of five weeks life was maintained by peritoneal dialysis.
Per Teisberg, Erik Enger
openaire   +3 more sources